Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID06193356

Detection of Endoscopic Resection Scars and Recurrence Among Non-experts Is Less Accurate Than Experts but Improves with a Short Learning Intervention

Led by University Hospital, Ghent · Updated on 2025-11-25

141

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying how well endoscopists of various experience levels can detect recurrent or residual adenoma (RRA) at the site of an endoscopic mucosal resection scar in colorectal cancer and polyp patients. The study aims to evaluate the accuracy of endoscopic imaging compared to histopathology and to assess the impact of a short video-based learning tool on improving detection skills. This research addresses the risk of missed RRA that could lead to post-colonoscopy colorectal cancer. Participants will first review 15 endoscopic images and answer questions about whether the images show a resection scar, signs of RRA, and their confidence level. They will also indicate how they would treat any detected RRA or suggest alternative diagnoses. After this initial assessment, participants will watch a video-based learning tool focused on detecting RRA. Then, they will evaluate 15 different images using the same questions. All data will be collected online anonymously using pseudonyms. Throughout the study, researchers will analyze responses to measure performance in detecting RRA before and after the learning intervention over a two-year period. They will also compare performance differences among endoscopists with various experience levels. The study uses a secure international image database and involves no direct patient procedures. Participants contribute through an online survey and learning modules, with outcomes focusing on improving non-expert detection of colorectal lesion recurrence.

CONDITIONS

Brief Title

Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Endoscopists of any experience level
Not Eligible

You will not qualify if you...

  • Adults who do not provide consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or virtual)

Diagnostic Evaluation

Duration - Up to 2 years

Participants assess endoscopic images prior to and after using a learning tool about detection of endoscopic resection scars and recurrence.

2 assessment sessions (one before and one after the learning tool)

Trial Site Locations

Total: 1 location

1

UZ Gent

Ghent, Belgium, 9000

Actively Recruiting

Loading map...

Research Team

D

David J trate, PhD

S

Sander Smeets, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

A Phase 1/2a Study Utilizing 64Cu-LNTH-1363S (64Cu Radiolabe...

Metastatic Sarcoma

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here